BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cuestas ML, Oubiña JR, Mathet VL. Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement. World J Pharmacol 2015; 4(1): 96-116 [DOI: 10.5497/wjp.v4.i1.96]
URL: https://www.wjgnet.com/1007-9327/full/v4/i1/96.htm
Number Citing Articles
1
Anhui Yang, Zhen Sun, Rui Liu, Xin Liu, Yue Zhang, Yulin Zhou, Ye Qiu, Xinrui Zhang. Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative StressFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.727605
2
Nouf Juaid, Amr Amin, Ali Abdalla, Kevin Reese, Zaenah Alamri, Mohamed Moulay, Suzan Abdu, Nabil Miled. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets InsightsInternational Journal of Molecular Sciences 2021; 22(19): 10774 doi: 10.3390/ijms221910774
3
Aswathy R Devan, Keechilat Pavithran, Bhagyalakshmi Nair, Maneesha Murali, Lekshmi R Nath. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinomaWorld Journal of Gastroenterology 2022; 28(36): 5250-5264 doi: 10.3748/wjg.v28.i36.5250
4
Tarun Sahu, Arundhati Mehta, Henu Kumar Verma, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 227 doi: 10.1016/B978-0-323-98807-0.00020-X